Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PRNB

Principia Biopharma (PRNB)

Principia Biopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PRNB
DateTimeSourceHeadlineSymbolCompany
17/02/202107:14Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRNBPrincipia Biopharma Inc
25/11/202000:00GlobeNewswire Inc.Patient Enrollment Concluded Early in PEGASUS Phase 3 Pemphigus TrialĀ for RilzabrutinibNASDAQ:PRNBPrincipia Biopharma Inc
08/10/202022:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:PRNBPrincipia Biopharma Inc
01/10/202020:06Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PRNBPrincipia Biopharma Inc
29/09/202007:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRNBPrincipia Biopharma Inc
29/09/202007:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRNBPrincipia Biopharma Inc
29/09/202007:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRNBPrincipia Biopharma Inc
29/09/202007:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202023:20Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202023:18Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202023:16Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202023:12Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202022:49Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202022:43Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202020:35Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202020:31Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:PRNBPrincipia Biopharma Inc
22/09/202020:44Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:PRNBPrincipia Biopharma Inc
22/09/202020:32Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:PRNBPrincipia Biopharma Inc
17/09/202022:01GlobeNewswire Inc.Principia Announces First Patient Dosed in Phase 2A Trial of Rilzabrutinib in IgG4-Related DiseaseNASDAQ:PRNBPrincipia Biopharma Inc
15/09/202006:34Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:PRNBPrincipia Biopharma Inc
11/09/202000:04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRNBPrincipia Biopharma Inc
10/09/202022:00GlobeNewswire Inc.Neoleukin Therapeutics Announces Appointment of Martin Babler to Board of DirectorsNASDAQ:PRNBPrincipia Biopharma Inc
28/08/202015:44Dow Jones NewsSanofi to Launch Tender Offer for Principia AcquisitionNASDAQ:PRNBPrincipia Biopharma Inc
26/08/202002:33Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:PRNBPrincipia Biopharma Inc
21/08/202020:01Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:PRNBPrincipia Biopharma Inc
21/08/202006:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRNBPrincipia Biopharma Inc
21/08/202006:20Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PRNBPrincipia Biopharma Inc
20/08/202003:50Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PRNBPrincipia Biopharma Inc
18/08/202020:01Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:PRNBPrincipia Biopharma Inc
18/08/202017:02Dow Jones NewsSanofi Buys MS-Drug Development Partner -- WSJNASDAQ:PRNBPrincipia Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:PRNB

Your Recent History

Delayed Upgrade Clock